T. Harada et al., DEVELOPMENT OF THE NEW POTENT NONPEPTIDE GPIIB IIIA ANTAGONIST NSL-95301 BY UTILIZING COMBINATORIAL TECHNIQUE/, Bioorganic & medicinal chemistry letters, 7(2), 1997, pp. 209-212
The synthetic study of new non-peptide gpIIb/IIIa antagonist, NSL-9530
1, is presented. The combinatorial technique was engaged in the lead c
ompound discovery process and optimization process to find (+)-NSL-953
01. The IC50 value of collagen induced platelet aggregation inhibitory
activity is 92 nM. (C) 1997, Elsevier Science Ltd.